SYS-CON MEDIA Authors: Bob Gourley, Sandi Mappic, Eric Brown, RealWire News Distribution, Kevin Benedict

News Feed Item

Global Therapeutic Vaccines Market 2014-2018

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/85rshn/global) has announced the addition of the "Global Therapeutic Vaccines Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.

The analysts forecast the Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.

The report, the Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Geographical Segmentation

08. Key Leading Countries

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Pipeline Analysis

17. Vendor Landscape

18. Key Vendor Analysis

Companies Mentioned:

  • AFFiRiS AG.
  • Agenus Inc.
  • Argos Therapeutics Inc
  • Bavarian Nordic A/S.
  • CEL-SCI Corp.
  • Celldex Therapeutics Inc.
  • Cytos Biotechnology AG
  • Dendreon Corp.
  • GlaxoSmithKline plc
  • GlobeImmune Inc.
  • NewLink GeneticsCorp.
  • NovaRx Corp.
  • Novartis International AG
  • Oncothyreon Inc.
  • TVAX Biomedical Inc.
  • TapImmune Inc
  • Vaccinogen Inc.
  • Vical Inc.

For more information visit http://www.researchandmarkets.com/research/85rshn/global

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.